WHO ICTRP trial
Carvedilol (drug) to treat liver disease.
CTRI/2023/01/048912 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2023/01/048912 |
|---|---|
| Public title | Carvedilol (drug) to treat liver disease. |
| Scientific title | To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Childs B and C Cirrhosis- A Randomized Controlled Trial" |
| Primary sponsor | Institute of Liver and Biliary Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: K769- Liver disease, unspecified |
| Interventions | Intervention1: Carvedilol at Day2 with Standard Medical Treatment: Arm A- Carvedilol will be initiated on day 2, at a dose of 3.125mg twice a day (6.25mg/day), along with standard management as per institutional protocol for AVB. All… |
| Registration date | Nov 1, 2023 |
| Target size | 100 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: